Geode Capital Management, LLC AXOVANT GENE THERAPIES LTD Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
N/A
-23,058 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
N/A
-35,255 Reduced 60.46%
23,058 $106,000
Q2 2020

Aug 13, 2020
BUY
N/A
14,088 Added 31.86%
58,313 $164,000
Q1 2020

May 14, 2020
BUY
N/A
8,378 Added 23.37%
44,225 $107,000
Q4 2019

Feb 13, 2020
BUY
N/A
15,732 Added 78.21%
35,847 $183,000
Q2 2019

Aug 14, 2019
BUY
N/A
20,115 New
20,115 $125,000
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email